Increased technological advances in the pharmaceutical sector, initiatives taken by the government and biotechnology companies, increased expenditure on RD along with available government funds for expansion and innovation are some of the key factors contributing to high CAGR of high throughput screening during forecast period.
According to the analysis of Reports and Data, the global high throughput screening market was valued at USD 15.22 Billion in 2020 and is expected to reach USD 35.03 Billion by the year 2028, at a CAGR of 10.8%. High throughput screening is a method using automation and big dataset processing to quickly assay the biological activity of various compounds, genes, and proteins. It is used for target identification, biological screening, protein stabilization, drug discovery and organismal based screening. Substrate concentration optimization, protein concentration and identification of physiologically relevant controls are the key factors for increasing demand in the market. It is one of the standards and famous methods of drug discovery in the pharmaceutical industry. The major goal is speeding up the process of drug discovery by screening a large number of compound stacks such as genomics, protein, peptide libraries, and combinational chemistry at a very fast rate of about 1000 compounds per day or a week
Key companies profiled in the report include
Agilent, Danaher, Thermo-Fischer Scientific, Tecan, Axxam, Merck Group, Biorad, Hamilton, Corning, BioTek, Aurora Biomed.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2268
The report is an investigative study that determines market growth and market scope on the basis of market trends, consumer behavior shifts, consumption and production patterns, product portfolio offered by the market, growth rate, drivers and constraints, financial positions, and existing challenges and limitations of the High Throughput Screening market.
The report discusses in detail the global production capacity, demand and supply ratio, market dynamics, and comprehensive analysis of the competitive landscape. It provides an industry-wide analysis of the market share of each players along with their business portfolio, production and manufacturing capacity, product portfolio, business expansion plans, financial standing, and strategic alliances such as mergers and acquisitions, joint ventures, and collaborations, among others.
The regional bifurcation of the market analyzes key market segments such as North America, Latin America, Europe, Asia Pacific, and Middle East Africa. The report discusses in detail the market growth, market size, revenue growth, market share, production and consumption, demand and supply, current and emerging trends, and technological developments in each region.
The key geographical regions analyzed in the market report are:
- North America (U.S.A., Canada)
- Europe (U.K., Italy, Germany, France, Rest of EU)
- AsiaPacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
High Throughput Screening Market Segmentation based on Types:
Product Type (Revenue, USD Million; 2018–2028)
- Reagents Assay Kits
- Instruments
- Consumables and Accessories
- Software Services
- Others
Technology Type (Revenue, USD Million; 2018–2028)
- Cell Based Assays
- Lab on chip
- Label free Assays
- Bioinformatics
- Others
Application Type (Revenue, USD Million; 2018–2028)
- Target Identification and Validation
- Primary and Secondary Screening
- Toxicology Assessment
- Other Applications
End Use (Revenue, USD Million; 2018–2028)
- Pharmaceutical and biotechnology Companies
- Academic and government Institutes
- Contract Research organizations
- Others
To know more about the report @ https://www.reportsanddata.com/report-detail/high-throughput-screening-market
Further key findings from the report suggest
- The high throughput screening market is growing at a CAGR of 8.9% in Asia-Pacific, followed by North America and Europe, with 7.7 % and 7.8% CAGR, respectively. Asia-Pacific is expected to grow at the fastest rate during the forecast period.
- As of 2018, the Reagents and Assay Kits segment is dominating the industry, which holds 39.5% of the global market. North American regional market is the chief revenue-generating source for this product segment, followed by Europe and Asia-Pacific regions
- This method is widely used in leveraging robotics, pharmaceutical industry, and automation to quickly test the biochemical activity in a large number of molecules.
- Reagent preparation, target identification, assay development, high throughput library screening, and compound management are various stages of high throughput screening.
- Asia-Pacific is expected to account for 8.9% of the global market. Developing nations such as China and India are likely to witness huge growth.
- An automated high throughput screening system can test about 100,000 target compounds in a day, and ultra-high system can test more than HTS System does i.e. more than 100,000 compounds per day. Due to this, their adoption of the drug discovery and development process has let to market expansion.
- Automation, Miniaturization, Assay Methodology has attracted huge investments by the pharmaceutical industry for high throughput screening technology, resulting in the growth of the market.
- High throughput screening is one of the standard and famous methods of drug discovery in the pharmaceutical industry. The major goal is speeding up the process of drug discovery by screening a large number of compound stacks such as genomics, protein, peptide libraries, and combinational chemistry at a very fast rate of about 1000 compounds per day or a week.
- Safety screening, target identification and validation, efficacy and monitoring of cell-based activity largely drive this industry, globally.
- Another factor for the growth of the market is huge investments in the healthcare sector and shifting inclination towards target market research.
- The use of data processing software, robotics, and sensitive detectors help to enhance process speed with accuracy. This process is capable of identifying active compounds, antibodies or genes modulating a particular biochemical pathway.
Thank you for reading our report. For further inquiry or query about customization, kindly get in touch with us to know more. Our team will clear your doubts and ensure the report is customized to meet your requirements.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
x
